There has been a significant uptick in the demand for mid-career toxicologists with pharmaceutical/biotech experience in the last few years. With strong venture capital funding for novel science companies, several firms are progressing to the point of needing a person to formulate a preclinical safety assessment plan. Most often, these companies seek a Director/Senior Director of Toxicology and/or Preclinical Development as the first such person in this capacity.
These roles always include the planning and oversight of external GLP and non-GLP testing, engagement with the FDA or peer global regulatory agencies and acting as a strategic project team member, contributing to drug development planning. Most companies look for a person who could grow a safety assessment group, as needed as the pipeline advances.
These positions generally require a PhD and at least five years of pharma experience with exposure to both discovery and development phase work. A person who can thrive in fast pace environments and collaborate well with their colleagues is another attribute that is needed.
At the present time, The Leyden Group is partnering with four such companies (two in Northern California, one in the Midwest and one in Philadelphia) that are seeking a person with this profile. All three companies are well funded and with good development partner relationships. Some flexibility for a remote work arrangement is viable, depending on one’s experience. A strong compensation and equity package is offered by all three companies.